Delivery Order SPE2DB22D3102-SPE2DB25FK9EM

Award Date 12/9/24
Potential Completion Date 12/10/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D3102
    Indefinite Delivery Contract
  • SPE2DB22D3102-SPE2DB25FK9EM
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,750.95 under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract provides for the delivery of 4,566,651,895 units of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, with a completion date of December 10, 2024. The award is not designated under any set-aside program, indicating open competition. Amerisourcebergen holds a $999,999,999 IDC with the DLA Troop Support Medical, as well as a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation, both of which cover a wide range of pharmaceutical and medical supply products to support various federal healthcare programs and agencies.

Generated 3/16/25, 12:53 AM